Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

Autor: Bernadette A M Heemskerk-Gerritsen, Antoinette Hollestelle, Christi J van Asperen, Irma van den Beek, Willemien J van Driel, Klaartje van Engelen, Encarna B Gómez Garcia, Joanne A de Hullu, Marco J Koudijs, Marian J E Mourits, Maartje J Hooning, Ingrid A Boere

Publikováno v: PLoS ONE, Vol 17, Iss 9, p e0275015 (2022)

IntroductionGermline BRCA1/2-associated epithelial ovarian cancer has been associated with better progression-free survival and overall survival than sporadic epithelial ovarian cancer, but conclusive data are lacking.MethodsWe matched 389 BRCA1-asso

Externí odkaz: https://doaj.org/article/78bf0cb2beca4827a30625f36863fc26

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women

Autor: Denise R. Nebgen, Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam, Monique M.A. Brood ‐ van Zanten, Barbara M. Norquist, Theresa Guise, Serge Rozenberg, Allison W. Kurian, Holly J. Pederson, Nese Yuksel, Rachel Michaelson‐Cohen, Sharon L. Bober, Agnaldo Lopes da Silva Filho, Nora Johansen, F. Guidozzi, D. Gareth Evans, Usha Menon, Sheryl A. Kingsberg, C. Bethan Powell, Giovanni Grandi, Claudia Marchetti, Michelle Jacobson, Donal J. Brennan, Martha Hickey

Publikováno v: Nebgen, D R, Domchek, S M, Kotsopoulos, J, de Hullu, J A, Crosbie, E J, Paramanandam, V S, van Zanten, M B, Norquist, B M, Guise, T, Rozenberg, S, Kurian, A W, Pederson, H J, Yuksel, N, Michaelson-Cohen, R, Bober, S L, da Silva Filho, A L, Johansen, N, Guidozzi, F, Evans, D G, Menon, U, Kingsberg, S A, Powell, C B, Grandi, G, Marchetti, C, Jacobson, M, Brennan, D J & Hickey, M 2023, ' Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women : Scoping review and international consensus recommendations ', BJOG: An International Journal of Obstetrics & Gynaecology . https://doi.org/10.1111/1471-0528.17511

Women at high inherited risk of ovarian cancer are offered risk-reducing salpingo-oophorectomy (RRSO) from age 35 to 45 years. Although potentially life-saving, RRSO may induce symptoms that negatively affect quality of life and impair long-term heal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b717e05d371e0e4e6d12aff74403e65
http://www.scopus.com/inward/record.url?scp=85158081710&partnerID=8YFLogxK

Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis

Autor: Janet R. Vos, Tjalling Bosse, Margreet G. E. M. Ausems, Majke H.D. van Bommel, Marjolijn J. L. Ligtenberg, Marian J.E. Mourits, Nicoline Hoogerbrugge, Vera M. Witjes, Joanne A. de Hullu

Publikováno v: Gynecologic Oncology, 164, 1, pp. 221-230
Gynecologic Oncology, 164, 221-230

Contains fulltext : 244552.pdf (Publisher’s version ) (Open Access) BACKGROUND: Histology restricted genetic predisposition testing of ovarian carcinoma patients is a topic of debate as the prevalence of BRCA1/2 pathogenic variants (PVs) in various

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e81d6e5290b677ad5f63593621af8644
https://doi.org/10.1016/j.ygyno.2021.10.072

First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants

Autor: Malou E. Gelderblom, Veerle Jaspers, Reinier P. Akkermans, Brigitte Slangen, Angele L. M. Oei, Alexandra A. van Ginkel, Huy Ngo, Joanna IntHout, Rosella P. M. G. Hermens, Joanne A. de Hullu, Jurgen M. J. Piek

Publikováno v: Acta Obstetricia et Gynecologica Scandinavica, 102, 3, pp. 257-269
Acta Obstetricia et Gynecologica Scandinavica, 102, 257-269. Wiley
Acta Obstetricia et Gynecologica Scandinavica, 102, 257-269

Contains fulltext : 291250.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Opportunistic salpingectomy (OS) refers to additional removal of the fallopian tubes during abdominal surgery performed for another medical indication, as prevention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a61bc865d1fc07013856dd77e6bc6c

Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

Autor: Vera M. Witjes, Jozé C. C. Braspenning, Nicoline Hoogerbrugge, Yvonne H. C. M. Smolders, Dorien M. A. Hermkens, Marian J. E. Mourits, Marjolijn J. L. Ligtenberg, Margreet G. E. M. Ausems, Joanne A. de Hullu

Publikováno v: Familial Cancer, 22, 1, pp. 1-11
Familial Cancer. SPRINGER
Familial Cancer, 22, 1-11

Contains fulltext : 291081.pdf (Publisher’s version ) (Open Access) Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an efficient prescreen for hereditary cancer testing, but may also guide treatment choice

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d95233bd0a7e5aaac528b5939b7a00